Clinical Trials Directory

Trials / Unknown

UnknownNCT05577481

Neuronavigation Guided iTBS With Personalized Target for Depression

Research on the Efficacy and Brain Network Mechanism of Personalized Targeting Intermittent Theta Burst Stimulation (iTBS) Based on Functional Magnetic Resonance Imaging for the Treatment of Major Depressive Disorder

Status
Unknown
Phase
Phase 2
Study type
Interventional
Enrollment
68 (estimated)
Sponsor
Xijing Hospital · Academic / Other
Sex
All
Age
18 Years – 60 Years
Healthy volunteers
Not accepted

Summary

The study will compare the efficacy of intermittent Theta Burst Stimulation (iTBS) with DLPFC-pgACC personalized target for major depressive disorder (MDD) and explore possible brain network mechanisms. The stimulated targets will be located by magnetic resonance imaging (MRI) based on functional MRI based on functional connectivity respectively. This study aims to identify that functional connectivity targeted iTBS protocols on DLPFC-pgACC personalized target have a better antidepressant efficacy compared the sham group and certify that pgACC is an effective potential effector target.

Conditions

Interventions

TypeNameDescription
COMBINATION_PRODUCTsham iTBS combined with antidepressantsTwo sessions of sham prolonged iTBS (1800 pulses) per day over 10 days combined with antidepressants.
COMBINATION_PRODUCTiTBS combined with antidepressantsTwo sessions of prolonged iTBS (1800 pulses) per day over 10 days combined with antidepressants.

Timeline

Start date
2023-07-10
Primary completion
2024-08-01
Completion
2024-08-01
First posted
2022-10-13
Last updated
2024-05-23

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT05577481. Inclusion in this directory is not an endorsement.